Global Dialysis Market Report: 2015 Edition
Dialysis is the artificial process of eliminating waste and unwanted water from the blood. It is carried out by using a special fluid called dialysate, a mixture of pure water and chemicals, is carefully controlled to pull wastes out of your blood without removing substances your body needs. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis removes wastes and water by circulating blood outside the body through an external filter, called a dialyzer and in peritoneal dialysis, wastes and water are removed from the blood inside the body using the peritoneum as a natural semipermeable membrane.
End stage renal disease (ESRD) is the last stage of chronic kidney disease. This is the situation when kidney is functioning below 10% of their normal function and they can no longer support a person’s day to day life. The common causes of ESRD include high blood pressure, atherosclerosis, and genetic disorders. ESRD treatment is carried out either by dialysis or kidney transplant.
The report analyzes the global and regional dialysis markets. Some of the factors driving the growth of dialysis market include: growing number of diabetic patients, increasing dialysis population and incidences of chronic and infectious diseases which has further increased the healthcare expenditure and pharmaceutical sales. Market dynamics like key trends and development, challenges and growth drivers are discussed in detail. The key players having the vicious competition with each other are: DaVita, Baxter, and Fresenius. These players are being profiled in the report along with their key financials and strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
End stage renal disease (ESRD) is the last stage of chronic kidney disease. This is the situation when kidney is functioning below 10% of their normal function and they can no longer support a person’s day to day life. The common causes of ESRD include high blood pressure, atherosclerosis, and genetic disorders. ESRD treatment is carried out either by dialysis or kidney transplant.
The report analyzes the global and regional dialysis markets. Some of the factors driving the growth of dialysis market include: growing number of diabetic patients, increasing dialysis population and incidences of chronic and infectious diseases which has further increased the healthcare expenditure and pharmaceutical sales. Market dynamics like key trends and development, challenges and growth drivers are discussed in detail. The key players having the vicious competition with each other are: DaVita, Baxter, and Fresenius. These players are being profiled in the report along with their key financials and strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. OVERVIEW
1.1 Chronic Kidney Disease (CKD)
1.2 End Stage Renal Disease (ESRD)
1.2.1 Treatments for ESRD
2. MARKET SIZE
2.1 Global Dialysis Market
Market Value
Market Segments
Hemodialysis
Peritoneal Dialysis
2.2 Regional Analysis
Regional Breakdown
Reimbursement Comparison
2.2.1 US
Market Overview
Per Capita Spend
2.2.2 Asia Pacific
Patient Growth Comparison
Market Segments in China
2.2.3 Europe, Middle East and Africa (EMEA)
Patient Growth
3. MARKET DYNAMICS
3.1 Key Trends and Developments
3.1.1 Distribution of Dialysis Clinics
3.1.2 Improved Technologies
3.2 Growth Drivers
3.2.1 Growing Number of Diabetic Patients Worldwide
3.2.2 Global Dialysis Patient Population
3.2.3 Meliorating Global Economy
3.2.4 Increasing Healthcare Expenditure
3.2.5 Increasing Cases of CKD and ESRD
3.2.6 Rising Ageing Population
3.3 Challenges
3.3.1 Associated Risks and After-effects of the Treatment
3.3.2 High Treatment Costs
4. COMPETITIVE LANDSCAPE
Global Market
North America
EMEA
Latin America
Asia Pacific
5. COMPANY PROFILES
5.1 DaVita Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Success through Acquisitions and Partnerships
5.2 Baxter International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Acquisitions & Collaborations
Innovation through Research and Development
5.3 Fresenius Medical Care
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Focus on Research and Development
Mergers and Acquisitions
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
1.1 Chronic Kidney Disease (CKD)
1.2 End Stage Renal Disease (ESRD)
1.2.1 Treatments for ESRD
2. MARKET SIZE
2.1 Global Dialysis Market
Market Value
Market Segments
Hemodialysis
Peritoneal Dialysis
2.2 Regional Analysis
Regional Breakdown
Reimbursement Comparison
2.2.1 US
Market Overview
Per Capita Spend
2.2.2 Asia Pacific
Patient Growth Comparison
Market Segments in China
2.2.3 Europe, Middle East and Africa (EMEA)
Patient Growth
3. MARKET DYNAMICS
3.1 Key Trends and Developments
3.1.1 Distribution of Dialysis Clinics
3.1.2 Improved Technologies
3.2 Growth Drivers
3.2.1 Growing Number of Diabetic Patients Worldwide
3.2.2 Global Dialysis Patient Population
3.2.3 Meliorating Global Economy
3.2.4 Increasing Healthcare Expenditure
3.2.5 Increasing Cases of CKD and ESRD
3.2.6 Rising Ageing Population
3.3 Challenges
3.3.1 Associated Risks and After-effects of the Treatment
3.3.2 High Treatment Costs
4. COMPETITIVE LANDSCAPE
Global Market
North America
EMEA
Latin America
Asia Pacific
5. COMPANY PROFILES
5.1 DaVita Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Success through Acquisitions and Partnerships
5.2 Baxter International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Acquisitions & Collaborations
Innovation through Research and Development
5.3 Fresenius Medical Care
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Focus on Research and Development
Mergers and Acquisitions
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
GFR across the Stages of CKD
Global Dialysis Market Value (2006-2013)
Global Dialysis Market Share- by Segments (2013)
Global Dialysis Market Size- by Segments (2013)
Global Dialysis Patients Share- by Treatment (2013)
Dialysis Patients Share- by Region (2013)
Dialysis Patients- by Region (2013)
Average Reimbursement Rate per Treatment (2013)
Medicare Spend per Dialysis Patient (2013)
Asia Pacific Dialysis Patients Growth (2013)
China’s Dialysis Market Share (2013)
China’s Hemodialysis Market Volume (2013)
Hemodialysis and Peritoneal Dialysis Share in China (2013)
EMEA Dialysis Patients Growth (2013)
Worldwide Breakdown of Center Dialysis & Home Dialysis (2013)
Worldwide Ownership of Dialysis Centers (2013)
Worldwide Dialysis Clinic Operator- by Region (2013)
Global Diabetes Population (2006-2013)
Global Diabetes Patients Population-by Region (2013)
Dialysis Patients Population Worldwide (2005-2015E)
Global GDP (2007-2013)
Global Health Care Expenditure per Capita (2007-2013)
Global Ageing Population (2008-2013)
Top 5 Dialysis Services Providers Worldwide (2013)
Worldwide Patients Market Share-by Provider (2013)
Global Dialysis Products – Market Share (2013)
Global Hemodialysis Products - Market Share (2013)
Global Peritoneal Products - Market Share (2013)
North America Patients Market Share- by Company (2013)
DaVita’s Revenue Share by Business Segments (2013)
DaVita Inc. - Revenue and Net Income Analysis (2009-2013)
Baxter’s Revenue by Business Segments (2013)
Baxter’s Revenues and Net Income (2009-2013)
Fresenius Medical Care Revenue Share by Business Segments (2013)
Fresenius Medical Care Revenue and Net Income (2009-2013)
Global Dialysis Market Forecast (2014F-2017F)
GFR across the Stages of CKD
Global Dialysis Market Value (2006-2013)
Global Dialysis Market Share- by Segments (2013)
Global Dialysis Market Size- by Segments (2013)
Global Dialysis Patients Share- by Treatment (2013)
Dialysis Patients Share- by Region (2013)
Dialysis Patients- by Region (2013)
Average Reimbursement Rate per Treatment (2013)
Medicare Spend per Dialysis Patient (2013)
Asia Pacific Dialysis Patients Growth (2013)
China’s Dialysis Market Share (2013)
China’s Hemodialysis Market Volume (2013)
Hemodialysis and Peritoneal Dialysis Share in China (2013)
EMEA Dialysis Patients Growth (2013)
Worldwide Breakdown of Center Dialysis & Home Dialysis (2013)
Worldwide Ownership of Dialysis Centers (2013)
Worldwide Dialysis Clinic Operator- by Region (2013)
Global Diabetes Population (2006-2013)
Global Diabetes Patients Population-by Region (2013)
Dialysis Patients Population Worldwide (2005-2015E)
Global GDP (2007-2013)
Global Health Care Expenditure per Capita (2007-2013)
Global Ageing Population (2008-2013)
Top 5 Dialysis Services Providers Worldwide (2013)
Worldwide Patients Market Share-by Provider (2013)
Global Dialysis Products – Market Share (2013)
Global Hemodialysis Products - Market Share (2013)
Global Peritoneal Products - Market Share (2013)
North America Patients Market Share- by Company (2013)
DaVita’s Revenue Share by Business Segments (2013)
DaVita Inc. - Revenue and Net Income Analysis (2009-2013)
Baxter’s Revenue by Business Segments (2013)
Baxter’s Revenues and Net Income (2009-2013)
Fresenius Medical Care Revenue Share by Business Segments (2013)
Fresenius Medical Care Revenue and Net Income (2009-2013)
Global Dialysis Market Forecast (2014F-2017F)
LIST OF TABLES
Stages of CKD
Renoprotective Strategies for Slowing Progression of CKD
Symptoms & Treatment of Renal Failure
Advantages and Disadvantages of Dialysis Methods
Total Spend per Patient per Year for US Dialysis Patients (2013)
Regional Breakdown of Center Dialysis and Home Dialysis (2013)
Competitors in North America Dialysis Market (2013)
Competitors in EMEA Dialysis Market (2013)
Competitors in Asia Pacific Dialysis Market (2013)
Competitors in Latin America Dialysis Market (2013)
Dependent & Independent Variables (2008–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Stages of CKD
Renoprotective Strategies for Slowing Progression of CKD
Symptoms & Treatment of Renal Failure
Advantages and Disadvantages of Dialysis Methods
Total Spend per Patient per Year for US Dialysis Patients (2013)
Regional Breakdown of Center Dialysis and Home Dialysis (2013)
Competitors in North America Dialysis Market (2013)
Competitors in EMEA Dialysis Market (2013)
Competitors in Asia Pacific Dialysis Market (2013)
Competitors in Latin America Dialysis Market (2013)
Dependent & Independent Variables (2008–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
